Early versus late JAK-STAT–IFN signaling distinguishes no rejection from subclinical to clinical TCMR after liver transplantation | Science Translational Medicine
Dynamic immune and JAK-STAT–IFN signaling across time points after liver transplant parallels rejection outcomes.
